Literature DB >> 8648144

beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice.

G J Christianson1, R L Blankenburg, T M Duffy, D Panka, J B Roths, A Marshak-Rothstein, D C Roopenian.   

Abstract

MRL-lpr/lpr mice develop a distinctive immunologic disease characterized by accumulation of unusually large numbers of T cells in the peripheral lymphoid organs. Most of the accumulating T cells express an alpha beta-TCR but are peculiar in that they express neither CD4 nor CD8 co-ligands. Concurrent with lymphoaccumulation of such double negative (DN) T cells, MRL-lpr/lpr mice develop a lethal systemic lupus erythematosus-like autoimmune syndrome. This study focuses on the role of MHC class I molecules in this latter pathologic process. Highly backcrossed class I molecule-deficient MRL and MRL-lpr mice carrying a functionally defective allele of the gene beta 2-microglobulin (B2m) were produced. Class I deficient MRL-lpr/lpr mice demonstrated a substantial reduction in DN T cells, confirming other reports indicating that most DN T cells arise from progenitors positively selected on MHC class I molecules. Significantly, class I-deficient MRL-lpr/lpr mice also demonstrated a diminution of every autoimmune disease indicator analyzed including hypergammaglobulinemia; autoantibodies including anti-DNA, anti-Smith antigen, and rheumatoid factor; and glomerulonephritis. The results indicate that class I-dependent T cells are crucial not only for the development of DN T cells, but for multiple features of the MRL-lpr/lpr systemic lupus erythematosus syndrome. Moreover, the pattern of hypergammaglobulinemia suggests that the requirement for MHC class I proteins is restricted temporally to later stages of the disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648144

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Monoclonal antibodies directed against human FcRn and their applications.

Authors:  Gregory J Christianson; Victor Z Sun; Shreeram Akilesh; Emanuele Pesavento; Gabriele Proetzel; Derry C Roopenian
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

2.  MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesis.

Authors:  Caroline G McPhee; Thomas J Sproule; Dong-Mi Shin; Jason A Bubier; William H Schott; Martin P Steinbuck; Lia Avenesyan; Herbert C Morse; Derry C Roopenian
Journal:  J Immunol       Date:  2011-09-30       Impact factor: 5.422

Review 3.  T cells and B cells in lupus nephritis.

Authors:  Mary H Foster
Journal:  Semin Nephrol       Date:  2007-01       Impact factor: 5.299

4.  MHC class I polymorphism in lupus-prone MRL/Mp mice.

Authors:  S L Peng; J Craft
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  Identification of potential genomic biomarkers for Sjögren's syndrome using data pooling of gene expression microarrays.

Authors:  Sadik A Khuder; Ibtisam Al-Hashimi; Anand B Mutgi; Nezam Altorok
Journal:  Rheumatol Int       Date:  2014-10-20       Impact factor: 2.631

6.  Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted.

Authors:  Jeremy S Tilstra; Lyndsay Avery; Ashley V Menk; Rachael A Gordon; Shuchi Smita; Lawrence P Kane; Maria Chikina; Greg M Delgoffe; Mark J Shlomchik
Journal:  J Clin Invest       Date:  2018-09-24       Impact factor: 14.808

7.  Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFbeta1-deficient mice.

Authors:  Ramireddy Bommireddy; Sandra J Engle; Ilona Ormsby; Gregory P Boivin; George F Babcock; Thomas Doetschman
Journal:  Cell Immunol       Date:  2005-03-29       Impact factor: 4.868

8.  Differential roles of osteopontin/Eta-1 in early and late lpr disease.

Authors:  G F Weber; H Cantor
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

9.  IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa mice.

Authors:  Caroline G McPhee; Jason A Bubier; Thomas J Sproule; Giljun Park; Martin P Steinbuck; William H Schott; Gregory J Christianson; Herbert C Morse; Derry C Roopenian
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

10.  Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.

Authors:  Julie A Lucas; Julia Menke; Whitney A Rabacal; Frederick J Schoen; Arlene H Sharpe; Vicki R Kelley
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.